These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3287070)

  • 21. [Pertussis vaccination with acellular vaccines. Tolerance--effectiveness--current vaccination recommendations].
    Liese JG; Stojanov S; Belohradsky BH
    Fortschr Med; 1997 Aug; 115(24):22-7. PubMed ID: 9410815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands.
    David S; Vermeer-de Bondt PE; van der Maas NA
    Vaccine; 2008 Oct; 26(46):5883-7. PubMed ID: 18775463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary immunization series for infants: comparison of two-component acellular and standard whole-cell pertussis vaccines combined with diphtheria-tetanus toxoids.
    Feldman S; Perry CS; Andrew M; Jones L; Moffitt JE; Lamb D; Meschievitz C
    South Med J; 1993 Mar; 86(3):269-75, 284. PubMed ID: 8451663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
    Halperin SA; King J; Law B; Mills E; Willems P
    Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tolerance of acellular pertussis vaccine booster injection in 15-20-month-old children].
    Mallet E; Puyt A; Arson S; Surbled V
    Arch Pediatr; 2000 Apr; 7(4):410-4. PubMed ID: 10793931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Gothenburg pertussis vaccine study.
    Trollfors B; Taranger J
    Dev Biol Stand; 1997; 89():49-51. PubMed ID: 9333568
    [No Abstract]   [Full Text] [Related]  

  • 27. Allergic disease at the age of 7 years after pertussis vaccination in infancy: results from the follow-up of a randomized controlled trial of 3 vaccines.
    Nilsson L; Kjellman NI; Bjorksten B
    Arch Pediatr Adolesc Med; 2003 Dec; 157(12):1184-9. PubMed ID: 14662571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A trial of acellular pertussis vaccine in hospital workers during the Cincinnati pertussis epidemic of 1993.
    Christie CD; Garrison KM; Kiely L; Gupta RK; Heubi J; Marchant CD
    Clin Infect Dis; 2001 Oct; 33(7):997-1003. PubMed ID: 11528571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines.
    Geier DA; Geier MR
    Brain Dev; 2004 Aug; 26(5):296-300. PubMed ID: 15165669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trial.
    Taranger J; Trollfors B; Knutsson N
    Dev Biol Stand; 1997; 89():109-12. PubMed ID: 9272340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Compare pertussis vaccines--but do it accurately].
    Olin P; Hallander HO
    Lakartidningen; 1996 Feb; 93(7):603-4. PubMed ID: 8642927
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients.
    Isomura S; Suzuki S; Sato Y
    Dev Biol Stand; 1985; 61():531-7. PubMed ID: 3914964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.
    Deforest A; Long SS; Lischner HW; Girone JA; Clark JL; Srinivasan R; Maguire TG; Diamond SA; Schiller RP; Rothstein EP
    Pediatrics; 1988 Feb; 81(2):237-46. PubMed ID: 3340474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pertussis vaccines: trials (and tribulations).
    Marwick C
    JAMA; 1988 Apr; 259(14):2057-9. PubMed ID: 3279239
    [No Abstract]   [Full Text] [Related]  

  • 36. [Should acellular pertussis vaccine be introduced into Sweden?].
    Kaijser B
    Lakartidningen; 1988 Oct; 85(42):3447. PubMed ID: 3199968
    [No Abstract]   [Full Text] [Related]  

  • 37. Acellular and whole-cell pertussis vaccines in Japan: report of a visit by US scientists.
    Cherry JD; Mortimer EA
    JAMA; 1987 Mar; 257(10):1375-6. PubMed ID: 3820445
    [No Abstract]   [Full Text] [Related]  

  • 38. Issues about pertussis vaccines.
    Hurley S; Bennet J; Gust I
    Lancet; 1998 Feb; 351(9103):678; author reply 678-9. PubMed ID: 9500362
    [No Abstract]   [Full Text] [Related]  

  • 39. Issues about pertussis vaccines.
    Miller E; Eskola J
    Lancet; 1998 Feb; 351(9103):677-8; author reply 678-9. PubMed ID: 9500361
    [No Abstract]   [Full Text] [Related]  

  • 40. Comments on "The double blind study comparing disease to placebo".
    Gunn CC
    Spine (Phila Pa 1976); 1978 Sep; 3(3):282. PubMed ID: 362555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.